Egis CEO resigns, Istvan Hodasz named as successor

BUDAPEST, Aug 26 (Reuters) - Hungarian drug producer Egis EGIS.BU said chief executive Agnes Gal had resigned effective Sept. 30, due to personal reasons, and will be succeeded by Istvan Hodasz.

Gal will remain on the board of Egis, a unit of France’s Servier, until her term expires in 2012, it said on Wednesday.

“Agnes Gal had set goals when she took over ... “She achieved all of these so when we say she’s leaving for personal reasons, it means just that,” spokeswoman Mariann Menthy said.

Hodasz, who has been on Egis's board since 2006, spent 10 years in sales and marketing management posts at Sanofi-Aventis SASY.PA and its predecessors prior to joining Egis.

Egis EGIS.BU posted a 14.9 percent rise in third-quarter net profit earlier this month and lifted its full-year sales target for some key export markets. (Reporting by Balazs Koranyi; Editing by Dan Lalor)